Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Bitcoin Price Prediction: Peter Schiff Fuds Michael Saylor’s Strategy Yield’s Model
Bitcoin price is trading at $64,500, down 0.2% over the past 24 hours, with a bad prediction from Peter Schiff. The headline numbe...
Tehran tests a more confrontational strategy
Iran's aggressive actions risk destabilizing regional security, potentially derailing diplomatic progress and impacting global oil...
Strategy tokenizes its stock on Solana for round-the-clock trading
Tokenizing stock on Solana enables 24/7 trading, bridging traditional and crypto markets, but introduces new custody and infrastru...
US Treasury sanctions Iranian firms running maritime extortion scheme with crypto payment ties
The sanctions highlight the growing complexity of enforcing international regulations in the digital age, necessitating global coo...
HastraFi launches AUTO markets on Solana backed by US auto loans
HastraFi's AUTO market on Solana could revolutionize DeFi by integrating real-world assets, but it also introduces new credit risk...
Robeco increases stake in Strategy by 11%, holding 133,755 shares
Robeco's increased stake in Strategy Inc highlights growing institutional confidence in Bitcoin, potentially boosting market stabi...